Sonoma Biotherapeutics, Inc.
Clinical trials sponsored by Sonoma Biotherapeutics, Inc., explained in plain language.
-
New RA drug enters first human safety trial
Disease control Recruiting nowThis study tests a new medicine called SBT777101 in 24 people with moderate-to-severe rheumatoid arthritis (RA). It is the first time this drug is given to humans, so the main goal is to check safety and side effects. Participants receive a single dose, and the dose is increased …
Phase: PHASE1 • Sponsor: Sonoma Biotherapeutics, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Gene-Modified cell therapy: researchers track Long-Term safety in arthritis and skin disease patients
Knowledge-focused Recruiting nowThis study monitors 36 people who previously received an experimental gene-modified regulatory T cell (Treg) therapy for rheumatoid arthritis or hidradenitis suppurativa. The goal is to check for any delayed side effects and see how long the modified cells last in the body. Parti…
Sponsor: Sonoma Biotherapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC